NeurologyLive® Mind Moments®

147: Improving Quality of Life in Movement Disorders Through Nonmotor Symptom Management


Listen Later

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, "Improving Quality of Life in Movement Disorders Through Nonmotor Symptom Management" Alex Dessy, MD, clinical assistant professor in movement disorders at Jefferson Health, shares a comprehensive look at modern-day care strategies for patients with Parkinson disease and other movement disorders. Dessy discusses the foundational role of detailed history-taking, exam-based observation, and phenomenology in diagnosing complex conditions, along with the growing utility of genetic and imaging tools. She also explains the challenges of managing nonmotor symptoms—like sleep disturbance, fatigue, and constipation—and how lifestyle strategies and interdisciplinary collaboration are often as vital as medication. Lastly, she emphasizes the importance of clear and compassionate communication with patients and families as neurology becomes increasingly therapeutic.


Looking for more Movement disorders discussion? Check out the NeurologyLive® Movement disorders clinical focus page.

Episode Breakdown:
  • 1:00 – How movement disorder diagnosis is approached through history, physical exam, and phenomenology
  • 4:05 – What makes certain movement disorder cases complex and how diagnostics like genetics and imaging are used
  • 6:20 – Neurology News Minute
  • 8:45 – How nonmotor symptoms in Parkinson’s (fatigue, constipation, sleep) are managed with lifestyle strategies
  • 12:30 – Approaching therapeutic communication and expectation-setting with patients and families

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • Eisai Showcases Promising 4-Year Data for Alzheimer Therapy Lecanemab at AAIC 2025
    • IHL-42X to Enter Phase 3 Trials for Obstructive Sleep Apnea Following Positive Phase 2 Data
    • FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine

    • Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
      ...more
      View all episodesView all episodes
      Download on the App Store

      NeurologyLive® Mind Moments®By NeurologyLive

      • 4.6
      • 4.6
      • 4.6
      • 4.6
      • 4.6

      4.6

      10 ratings


      More shows like NeurologyLive® Mind Moments®

      View all
      NEJM This Week by NEJM Group

      NEJM This Week

      321 Listeners

      Neurology® Podcast by American Academy of Neurology

      Neurology® Podcast

      302 Listeners

      Practical Neurology Podcast by BMJ Group

      Practical Neurology Podcast

      49 Listeners

      The Clark Howard Podcast by Clark Howard

      The Clark Howard Podcast

      5,457 Listeners

      JAMA Neurology Author Interviews by JAMA Network

      JAMA Neurology Author Interviews

      12 Listeners

      BMJ Best Practice Podcast by BMJ Group

      BMJ Best Practice Podcast

      21 Listeners

      Neurology Today in 5 by American Academy of Neurology

      Neurology Today in 5

      25 Listeners

      Neurology Minute by American Academy of Neurology

      Neurology Minute

      133 Listeners

      Dateline NBC by NBC News

      Dateline NBC

      47,622 Listeners

      The Ezra Klein Show by New York Times Opinion

      The Ezra Klein Show

      16,096 Listeners

      Movers and Shakers: a podcast about life with Parkinson's by Podot

      Movers and Shakers: a podcast about life with Parkinson's

      106 Listeners

      Continuum Audio by American Academy of Neurology

      Continuum Audio

      80 Listeners

      Chanticleer by Australian Financial Review

      Chanticleer

      21 Listeners

      The Top Line by Fierce Life Sciences

      The Top Line

      13 Listeners

      The Economics Show by Financial Times

      The Economics Show

      140 Listeners